Picton Mahoney Asset Management Voyager Therapeutics, Inc. Transaction History
Picton Mahoney Asset Management
- $5.81 Billion
- Q1 2025
A detailed history of Picton Mahoney Asset Management transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 4,328 shares of VYGR stock, worth $14,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,328
Previous 5,883
26.43%
Holding current value
$14,888
Previous $33,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VYGR
# of Institutions
121Shares Held
34.8MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$18.7 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$18.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$13.5 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$11 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.84 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $133M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...